Video

Anita Clayton, MD: Women's Issues in Psychiatry

Author(s):

Postpartum depression rates have increased since the COVID-19 pandemic.

Many women every year are faced with postpartum psychiatric concerns following giving birth.

And the rates and severity of postpartum depression and postpartum anxiety has only increased during the COVID-19 pandemic.

Anita Clayton, MD, chair of psychiatry and neurobehavioral sciences at the University of Virginia School of Medicine, explained in an interview with HCPLive® why many women are facing these postpartum concerns.

“So I’d say that women who do have postpartum depression often attribute it to other things,” Clayton said. “The baby is up in the night and they need to breastfeed it. That they aren’t getting much sleep. That they need to lose weight.”

Clayton recently co-chaired the 2022 Annual Psychiatric Times™ World CME Conference in San Diego from August 11-13.

Clayton also discussed how critical it is for OBGYN doctors to collaborate with psychiatrists when an issue is identified.

“I think the area that OBGYN’s are most concerned about is postpartum depression from their mothers or just from neglect because the mother is depressed,” she said.

Clayton went on to say there is a recommended screening tool commonly used in the US for postpartum depression and there is also an intravenous treatment that has shown promise in this patient population.

Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.